ArticleAnnals of hematology2025

Optimizing individualized therapy decision-making in multiple myeloma (MM): integration and impact of the Revised Myeloma Comorbidity Index in the MM-tumor board.

Esther Dreyling et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.